Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)
CNY 7.57
(0.53%)
CNY 7.57
(0.53%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.2 Billion CNY | -2.69% |
| 2022 | 1.24 Billion CNY | 17.95% |
| 2021 | 1.05 Billion CNY | 35.53% |
| 2020 | 777.29 Million CNY | -22.7% |
| 2019 | 1 Billion CNY | 3.59% |
| 2018 | 970.71 Million CNY | 37.88% |
| 2017 | 704.01 Million CNY | 333.47% |
| 2016 | 162.41 Million CNY | 38.68% |
| 2015 | 117.11 Million CNY | -32.24% |
| 2014 | 172.83 Million CNY | -27.56% |
| 2013 | 238.58 Million CNY | -9.69% |
| 2012 | 264.18 Million CNY | 14.2% |
| 2011 | 231.34 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 234.71 Million CNY | 47.49% |
| 2024 Q1 | 357.48 Million CNY | -6.45% |
| 2024 Q2 | 159.14 Million CNY | -55.48% |
| 2023 Q2 | 213.93 Million CNY | -49.04% |
| 2023 FY | 1.2 Billion CNY | -2.69% |
| 2023 Q4 | 382.13 Million CNY | 97.65% |
| 2023 Q3 | 193.33 Million CNY | -9.63% |
| 2023 Q1 | 419.78 Million CNY | -20.97% |
| 2022 FY | 1.24 Billion CNY | 17.95% |
| 2022 Q3 | 232 Million CNY | 41.09% |
| 2022 Q2 | 164.44 Million CNY | -47.79% |
| 2022 Q1 | 314.98 Million CNY | -2.05% |
| 2022 Q4 | 531.16 Million CNY | 128.94% |
| 2021 Q3 | 196.39 Million CNY | 23.78% |
| 2021 Q1 | 376.87 Million CNY | 28.61% |
| 2021 Q2 | 158.65 Million CNY | -57.9% |
| 2021 Q4 | 321.57 Million CNY | 63.74% |
| 2021 FY | 1.05 Billion CNY | 35.53% |
| 2020 Q2 | 129.23 Million CNY | -37.87% |
| 2020 Q3 | 147.01 Million CNY | 13.76% |
| 2020 Q4 | 293.03 Million CNY | 99.32% |
| 2020 Q1 | 208.01 Million CNY | -47.45% |
| 2020 FY | 777.29 Million CNY | -22.7% |
| 2019 Q2 | 141.31 Million CNY | -49.24% |
| 2019 Q1 | 278.4 Million CNY | -22.68% |
| 2019 FY | 1 Billion CNY | 3.59% |
| 2019 Q4 | 395.88 Million CNY | 108.36% |
| 2019 Q3 | 190 Million CNY | 34.46% |
| 2018 Q3 | 182.57 Million CNY | 8.87% |
| 2018 FY | 970.71 Million CNY | 37.88% |
| 2018 Q4 | 360.05 Million CNY | 97.21% |
| 2018 Q2 | 167.7 Million CNY | -35.59% |
| 2018 Q1 | 260.37 Million CNY | -32.12% |
| 2017 Q1 | 30.78 Million CNY | -36.31% |
| 2017 Q4 | 383.57 Million CNY | 116.3% |
| 2017 Q2 | 112.3 Million CNY | 264.78% |
| 2017 Q3 | 177.33 Million CNY | 57.91% |
| 2017 FY | 704.01 Million CNY | 333.47% |
| 2016 Q4 | 48.33 Million CNY | 32.06% |
| 2016 Q1 | 27.03 Million CNY | 26.93% |
| 2016 Q2 | 50.43 Million CNY | 86.53% |
| 2016 Q3 | 36.6 Million CNY | -27.43% |
| 2016 FY | 162.41 Million CNY | 38.68% |
| 2015 Q3 | 25.76 Million CNY | -12.78% |
| 2015 FY | 117.11 Million CNY | -32.24% |
| 2015 Q4 | 21.3 Million CNY | -17.3% |
| 2015 Q2 | 29.53 Million CNY | -27.1% |
| 2015 Q1 | 40.51 Million CNY | 36.56% |
| 2014 Q2 | 49.49 Million CNY | -4.48% |
| 2014 Q3 | 41.85 Million CNY | -15.43% |
| 2014 Q4 | 29.66 Million CNY | -29.12% |
| 2014 Q1 | 51.81 Million CNY | 0.0% |
| 2014 FY | 172.83 Million CNY | -27.56% |
| 2013 FY | 238.58 Million CNY | -9.69% |
| 2012 FY | 264.18 Million CNY | 14.2% |
| 2011 FY | 231.34 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| China National Complete Plant Import & Export Corporation Limited | 3.06 Billion CNY | 60.578% |